Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters

Thrombosis Research

Volumn 126, Issue 1, 2010, Pages

  Diaz Ricart, Maribel ^a   Brunso, Lucas ^a   Pino, Marc ^a   Navalon, Fulgencio ^a   Jou, Josep M ^a   Heras, Magda ^a   White, James G ^b   Escolar, Gines ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

EDTA; Mean platelet component; P selectin; Platelet activation; Sample stability; Tyrosine phosphorylation

Indexed keywords

EDETIC ACID; EDETIC ACID DERIVATIVE; PADGEM PROTEIN; TYRPHOSTIN; WORTMANNIN; ANTICOAGULANT AGENT;

ANALYZER; ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; CELL DENSITY; CELL GRANULE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW TEMPERATURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ROOM TEMPERATURE; SIGNAL TRANSDUCTION; STANDARDIZATION; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME; BLOOD ANALYSIS; BLOOD EXAMINATION; CELL SEPARATION; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE; METABOLISM; PHYSIOLOGY; PROCEDURES; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

ANTICOAGULANTS; BLOOD CHEMICAL ANALYSIS; BLOOD PLATELETS; CELL SEPARATION; EDETIC ACID; ERYTHROCYTES; FLOW CYTOMETRY; HEMATOLOGIC TESTS; HUMANS; MICROSCOPY, ELECTRON; PLATELET ACTIVATION; PLATELET COUNT;

EID: 77953119058     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.04.002     Document Type: Article

References (37)

1. Macey M.G., Carty E., Webb L., Chapman E.S., Zelmanovic D., Okrongly D., et al. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. Cytometry 38 (1999) 250-255
2. Brummitt D.R., and Barker H.F. The determination of a reference range for new platelet parameters produced by the Bayer ADVIA120 full blood count analyser. Clin Lab Haematol 22 (2000) 103-107
3. Giacomini A., Legovini P., Gessoni G., Antico F., Valverde S., Salvadego M.M., et al. Platelet count and parameters determined by the Bayer ADVIA 120 in reference subjects and patients. Clin Lab Haematol 23 (2001) 181-186
4. Ahnadi C.E., Sabrinah C.E., Lepine M., Okrongly D., Pujol-Moix N., Hernandez A., et al. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy. Thromb Haemost 90 (2003) 940-948
5. Bae S.H., Lee J., Roh K.H., and Kim J. Platelet activation in patients with diabetic retinopathy. Korean J Ophthalmol 17 (2003) 140-144
6. Chapman E.S., Sorette M., Hetherington E., Zelmanovic D., Kling G., Dugailliez J., et al. A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination. Thromb Haemost 89 (2003) 1004-1015
7. Giacomini A., Legovini P., Antico F., Valverde S., Salvadego M.M., Manoni F., et al. Assessment of in vitro platelet activation by Advia 120 platelet parameters. Lab Hematol 9 (2003) 132-137
8. Ahnadi C.E., Boughrassa F.F., Chapman-Montgomery E.S., Poisson V., Gervais A., Okrongly D., et al. Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty. Thromb Haemost 92 (2004) 1207-1213
9. White J.G. EDTA-induced changes in platelet structure and function: clot retraction. Platelets 11 (2000) 49-55
10. White J.G., and Escolar G. EDTA-induced changes in platelet structure and function: adhesion and spreading. Platelets 11 (2000) 56-61
11. White J.G., Krumwiede M.D., and Escolar G. EDTA induced changes in platelet structure and function: influence on particle uptake. Platelets 10 (1999) 327-337
12. White J.G. Effects of ethylenediamine tetraacetic acid (EDTA) on platelet structure. Scand J Haematol 5 (1968) 241-254
13. Macey M., Azam U., McCarthy D., Webb L., Chapman E.S., Okrongly D., et al. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem 48 (2002) 891-899
14. Yano H., Nakanishi S., Kimura K., Hanai N., Saitoh Y., Fukui Y., et al. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268 (1993) 25846-25856
15. Gazit A., Yaish P., Gilon C., and Levitzki A. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32 (1989) 2344-2352
16. Lozano M., Escolar G., Mazzara R., Connor J., White J.G., Delecca D., et al. Effects of the addition of second-messenger effects to platelet concentrates separated from whole-blood donations and stored at 4 °C or -80 °C. Transfusion 40 (2000) 527-534
17. Perez-Pujol S., Lozano M., Escolar G., Diaz-Ricart M., Pujolmoix N., and Ordinas A. Glycoproteins on platelet membrane in inherit macrothrombocytopenias. Thromb Res 112 (2003) 233-237
18. White J.G. The morphology of platelet function. Meth Hematol 4 (1983) 1-25
19. Escolar G., Leistikow E., and White J.G. The fate of the open canalicular system in surface and suspension-activated platelets. Blood 74 (1989) 1983-1988
20. Hazelwood S., Shotelersuk V., Wildenberg S.C., Chen D., Iwata F., Kaiser-Kupfer M.I., et al. Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. Am J Hum Genet 61 (1997) 1088-1094
21. Escolar G., Monteagudo J., Villamor N., Garrido M., Castillo R., and Ordinas A. Ristocetin induces platelet aggregation: a morphological demonstration. Br J Haematol 69 (1988) 379-386
22. Diaz-Ricart M., Fuste B., Estebanell E., Tonda R., Lozano M., Escolar G., et al. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib. Platelets 16 (2005) 453-461
23. Boos C.J., Beevers G.D., and Lip G.Y. Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension. Ann Med 39 (2007) 72-78
24. Chung I., Choudhury A., and Lip G.Y. Platelet activation in acute, decompensated congestive heart failure. Thromb Res 120 (2007) 709-713
25. Chung I., Choudhury A., Patel J., and Lip G.Y. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity. J Intern Med 263 (2008) 313-321
26. Segura D., Monreal L., Armengou L., Tarancon I., Brugues R., and Escolar G. Mean platelet component as an indicator of platelet activation in foals and adult horses. J Vet Intern Med 21 (2007) 1076-1082
27. White J.G. Effects of ethylenediamine tetracetic acid (EDTA) on platelet structure. Scand J Haematol 5 (1968) 241-254
28. White J.G., Krumwiede M.D., and Escolar G. EDTA induced changes in platelet structure and function: influence on particle uptake. Platelets 10 (1999) 327-337
29. Ma Y., and Wong K. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets. Platelets 18 (2007) 451-459
30. Hwang D.L., Yen C.F., and Nadler J.L. Effect of extracellular magnesium on platelet activation and intracellular calcium mobilization. Am J Hypertens 5 (1992) 700-706
31. Gawaz M., Ott I., Reininger A.J., and Neumann F.J. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost 72 (1994) 912-918
32. Hardy E., Glenn J., Heptinstall S., Rubin P.C., and Horn E.H. Magnesium modifies the responses of platelets to inhibitory agents which act via cAMP. Thromb Haemost 74 (1995) 1132-1137
33. Morello F., Perino A., and Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 82 (2009) 261-271
34. Woods V.L., Wolff L.E., and Keller D.M. Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not to other extracellular proteins. J Biol Chem 261 (1986) 15242-15251
35. Gachet C., Hanau D., Spehner D., Brisson C., Garaud J.C., Schmitt D.A., et al. AlphaIIbbeta3 integrin dissociation induced by EDTA results in morphological changes of the platelet surface-connected canalicular system with differential location of the 2 separate subunits. J Cell Biol 120 (1993) 1021-1030
36. Escolar G., and White J.G. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies. Thromb Haemost 83 (2000) 371-386
37. Grant R.A., Zucker M.B., and McPherson J. ADP-induced inhibition of von Willebrand factor-mediated platelet agglutination. Am J Physiol 230 (1976) 1406-1410